AstraZeneca PLC
AZN
#48

¥1,241.37

7.02%

已结束: Oct 30, 20:00:00 PM UTC+00:00

¥1,235.68

0.45%

盘前交易: Nov 02, 10:08:23 AM UTC+00:00

AstraZeneca PLC Info

市值: ¥1.91T
0.45%
日交易量: ¥10.53M
市盈率: 130.34
股息率: 1.22%
EPS: ¥9.51
52周范围: ¥535.25¥1.41K

网站

www.astrazeneca.com

币种

股票

员工

94300

创立日期

Apr 6, 1999

主要交易平台

Nasdaq

CIK 编号

0000901832

代币化股票数据

平均代币化价格: ¥1.2K
价差: +¥30.24(-2.45%)
代币化市值: ¥778.73K
1.74%
代币化交易量（24 小时）: ¥326.97K
0.07%

发行人

Backed Assets

合约列表

浏览器

solscan.io

AZN对美元转换器

AZN

CNY

价格表现

低
¥1.23K

高
¥1.24K

加载数据中

请稍候，我们正在加载图表数据

AstraZeneca PLC社区

关于AstraZeneca PLC

What is AstraZeneca PLC?

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.